{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:27:58Z","timestamp":1769596078126,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cardiacep.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ccep.2025.10.005","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:24:23Z","timestamp":1763767463000},"page":"79-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiarrhythmic Medications for Acute Management of Ventricular Arrhythmias"],"prefix":"10.1016","volume":"18","author":[{"given":"Jose Fernandez","family":"Sanchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean Paul","family":"Gaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos N.","family":"Aronis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ccep.2025.10.005_bib1","first-page":"e210","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"issue":"40","key":"10.1016\/j.ccep.2025.10.005_bib2","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.ccep.2025.10.005_bib3","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2022.01.050","article-title":"Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia","volume":"79","author":"Arenal","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.ccep.2025.10.005_bib4","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.122.059598","article-title":"Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial","volume":"145","author":"Della Bella","year":"2022","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ccep.2025.10.005_bib5","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1161\/CIRCULATIONAHA.122.060039","article-title":"First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial","volume":"145","author":"Tung","year":"2022","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ccep.2025.10.005_bib6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa2409501","article-title":"Catheter ablation or antiarrhythmic drugs for ventricular tachycardia","volume":"392","author":"Sapp","year":"2025","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ccep.2025.10.005_bib7","first-page":"1141","article-title":"Outcomes of catheter ablation of ventricular tachycardia based on etiology in nonischemic heart disease: an international ventricular tachycardia ablation center collaborative study","volume":"4","author":"Vaseghi","year":"2018","journal-title":"JACC"},{"issue":"9","key":"10.1016\/j.ccep.2025.10.005_bib8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacep.2018.06.014","article-title":"Ventricular tachycardia ablation in nonischemic cardiomyopathy","volume":"4","author":"Zeppenfeld","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"9","key":"10.1016\/j.ccep.2025.10.005_bib9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jacep.2020.04.025","article-title":"Prevalence and prognostic impact of pathogenic variants in patients with dilated cardiomyopathy referred for ventricular tachycardia ablation","volume":"6","author":"Ebert","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"10.1016\/j.ccep.2025.10.005_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12030930","article-title":"Idiopathic ventricular tachycardia","volume":"12","author":"Ward","year":"2023","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.005_bib11","first-page":"1443","article-title":"Catheter ablation of fascicular ventricular tachycardia","volume":"8","author":"Liu","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccep.2025.10.005_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10840-012-9706-1","article-title":"Clinical characteristics and acute results of catheter ablation for outflow tract ventricular tachycardia or premature beats","volume":"35","author":"Valk","year":"2012","journal-title":"J Intervent Card Electrophysiol"},{"issue":"22","key":"10.1016\/j.ccep.2025.10.005_bib13","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.jacc.2023.03.424","article-title":"Multidisciplinary critical care management of electrical storm","volume":"81","author":"Jentzer","year":"2023","journal-title":"JACC"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.005_bib14","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/jce.13944","article-title":"Premature ventricular contraction diurnal profiles predict distinct clinical characteristics and beta-blocker responses","volume":"30","author":"Hamon","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"17","key":"10.1016\/j.ccep.2025.10.005_bib15","first-page":"1329","article-title":"Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study","volume":"38","author":"Ortiz","year":"2016","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.005_bib16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/hrt.46.6.679","article-title":"Response of recurrent sustained ventricular tachycardia to verapamil","volume":"46","author":"Belhassen","year":"1981","journal-title":"Br Heart J"},{"issue":"10","key":"10.1016\/j.ccep.2025.10.005_bib17","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.jacep.2023.05.040","article-title":"Purkinje-related ventricular tachycardia and ventricular fibrillation: solved and unsolved questions","volume":"9","author":"Nogami","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"issue":"8","key":"10.1016\/j.ccep.2025.10.005_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/CIRCULATIONAHA.111.023846","article-title":"Sudden cardiac death caused by coronary heart disease","volume":"125","author":"Myerburg","year":"2012","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ccep.2025.10.005_bib19","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.005_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jacep.2019.09.013","article-title":"Focal ventricular tachycardias in structural heart disease: prevalence, characteristics, and clinical outcomes after catheter ablation","volume":"6","author":"Anderson","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.005_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1540-8167.2004.03189.x","article-title":"Identification and ablation of three types of ventricular tachycardia involving the his-purkinje system in patients with heart disease","volume":"15","author":"Lopera","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"10.1016\/j.ccep.2025.10.005_bib22","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.hrthm.2016.07.001","article-title":"Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease","volume":"13","author":"Kumar","year":"2016","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.ccep.2025.10.005_bib23","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/cts.13650","article-title":"Lidocaine as an anti-arrhythmic drug: are there any indications left?","volume":"16","author":"G\u00fcler","year":"2023","journal-title":"Clin Transl Sci"},{"issue":"12","key":"10.1016\/j.ccep.2025.10.005_bib24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccep.2025.10.005_bib25","article-title":"Long-term follow-up data on flecainide use as an antiarrhythmic in arrhythmogenic right ventricular cardiomyopathy","author":"Gaine","year":"2025","journal-title":"JACC"},{"issue":"2","key":"10.1016\/j.ccep.2025.10.005_bib26","first-page":"278","article-title":"Safety and efficacy of flecainide associated with beta-blockers in arrhythmogenic right ventricular cardiomyopathy","volume":"24","author":"Rolland","year":"2022","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.ccep.2025.10.005_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae049","volume":"26","author":"Lenarczyk","year":"2024","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.005_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/CCM.0b013e3181fd6ad7","article-title":"Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction","volume":"39","author":"Piccini","year":"2011","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccep.2025.10.005_bib29","article-title":"Prophylactic lidocaine for myocardial infarction","volume":"2015","author":"Mart\u00ed-Carvajal","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ccep.2025.10.005_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/europace\/euz290","article-title":"Quinidine-responsive out-of-hospital polymorphic ventricular tachycardia in patients with coronary heart disease","volume":"22","author":"Viskin","year":"2020","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.ccep.2025.10.005_bib31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jacep.2021.03.024","article-title":"Quinidine in the management of recurrent ventricular arrhythmias: a reappraisal","volume":"7","author":"Li","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"29","key":"10.1016\/j.ccep.2025.10.005_bib32","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/eurheartj\/ehab275","article-title":"Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry","volume":"42","author":"Steinberg","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ccep.2025.10.005_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jacep.2022.02.017","article-title":"Congenital long QT syndrome","volume":"8","author":"Krahn","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"issue":"20","key":"10.1016\/j.ccep.2025.10.005_bib34","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2012.07.046","article-title":"Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol","volume":"60","author":"Chockalingam","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ccep.2025.10.005_bib35","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.116.021823","article-title":"Clinical aspects of type 3 long-QT syndrome: an international multicenter study","volume":"134","author":"Wilde","year":"2016","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ccep.2025.10.005_bib36","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT Syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2025.10.005_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.007280","article-title":"Mexiletine shortens the QT interval in patients with potassium channel-mediated type 2 long QT syndrome","volume":"12","author":"Bos","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"19","key":"10.1016\/j.ccep.2025.10.005_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197051","article-title":"Mechanisms of arrhythmias in the Brugada syndrome","volume":"21","author":"Blok","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.ccep.2025.10.005_bib39","first-page":"386","article-title":"Brugada syndrome","volume":"8","author":"Krahn","year":"2022","journal-title":"JACC"},{"issue":"3 Pt 2","key":"10.1016\/j.ccep.2025.10.005_bib40","first-page":"H704","article-title":"Quinidine-induced inhibition of transient outward current in cardiac muscle","volume":"253","author":"Imaizumi","year":"1987","journal-title":"Am J Physiol"},{"issue":"Suppl 3","key":"10.1016\/j.ccep.2025.10.005_bib41","doi-asserted-by":"crossref","first-page":"A35","DOI":"10.1136\/heartjnl-2011-300867.99","article-title":"Studies on ionic mechanisms of the effects of isoproterenol on Brugada syndrome","volume":"97","author":"Zhengrong","year":"2011","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.005_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccep.2025.10.005_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/CIRCRESAHA.120.316819","article-title":"RYR2 channel inhibition is the principal mechanism of flecainide action in CPVT","volume":"128","author":"Kryshtal","year":"2021","journal-title":"Circ Res"},{"issue":"17","key":"10.1016\/j.ccep.2025.10.005_bib44","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2018.02.056","article-title":"Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator","volume":"71","author":"Chatzidou","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccep.2025.10.005_bib45","first-page":"242","article-title":"Posttraumatic stress and the implantable cardioverter-defibrillator patient","volume":"4","author":"Sears","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.005_bib46","first-page":"657","article-title":"Deep sedation as temporary bridge to definitive treatment of ventricular arrhythmia storm","volume":"9","author":"Bundgaard","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.ccep.2025.10.005_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5158362","article-title":"Dexmedetomidine reduces incidences of ventricular arrhythmias in adult patients: a meta-analysis","volume":"2022","author":"Zhong","year":"2022","journal-title":"Cardiol Res Pract"},{"issue":"16","key":"10.1016\/j.ccep.2025.10.005_bib48","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.120.047468","article-title":"Effectiveness of deep sedation for patients with intractable electrical storm refractory to antiarrhythmic drugs","volume":"142","author":"Martins","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccep.2025.10.005_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-76663-9","article-title":"Efficacy of stellate ganglion block in treatment of electrical storm: a systematic review and meta-analysis","volume":"14","author":"Motazedian","year":"2024","journal-title":"Sci Rep"},{"issue":"16","key":"10.1016\/j.ccep.2025.10.005_bib50","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non\u2013ST-elevation acute coronary syndromesthe MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.005_bib51","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2018.04.086","article-title":"Ranolazine in high-risk patients with implanted cardioverter-defibrillators","volume":"72","author":"Zareba","year":"2018","journal-title":"JACC"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.005_bib52","first-page":"754","article-title":"Reduction in ventricular tachyarrhythmia burden in patients enrolled in the RAID trial","volume":"8","author":"Younis","year":"2022","journal-title":"JACC"},{"issue":"3","key":"10.1016\/j.ccep.2025.10.005_bib53","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejphar.2011.07.025","article-title":"Electrophysiological effects of ivabradine in dog and human cardiac preparations: potential antiarrhythmic actions","volume":"668","author":"Koncz","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.ccep.2025.10.005_bib54","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/jcp.24507","article-title":"Ivabradine protects against ventricular arrhythmias in acute myocardial infarction in the rat","volume":"229","author":"Mackiewicz","year":"2014","journal-title":"J Cell Physiol"},{"issue":"Supplement_1","key":"10.1016\/j.ccep.2025.10.005_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad122.300","article-title":"Association of ivabradin use with ventricular arrhythmias in heart failure patients","volume":"25","author":"Pay","year":"2023","journal-title":"EP Europace"},{"issue":"21","key":"10.1016\/j.ccep.2025.10.005_bib56","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1111\/bph.13563","article-title":"The novel late Na+ current inhibitor, GS-6615 (eleclazine) and its anti-arrhythmic effects in rabbit isolated heart preparations","volume":"173","author":"Rajamani","year":"2016","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.ccep.2025.10.005_bib57","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.hrthm.2016.10.021","article-title":"Eleclazine, an inhibitor of the cardiac late sodium current, is superior to flecainide in suppressing catecholamine-induced ventricular tachycardia and T-wave alternans in an intact porcine model","volume":"14","author":"Bacic","year":"2017","journal-title":"Heart Rhythm"},{"issue":"suppl_1","key":"10.1016\/j.ccep.2025.10.005_bib58","first-page":"A15415","volume":"136","author":"Cossu","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2025.10.005_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117075","article-title":"IK1 channel agonist zacopride suppresses ventricular arrhythmias in conscious rats with healing myocardial infarction","volume":"239","author":"Zhai","year":"2019","journal-title":"Life Sci"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918225000796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918225000796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T20:40:06Z","timestamp":1769546406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918225000796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1877918225000796"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2025.10.005","relation":{},"ISSN":["1877-9182"],"issn-type":[{"value":"1877-9182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiarrhythmic Medications for Acute Management of Ventricular Arrhythmias","name":"articletitle","label":"Article Title"},{"value":"Cardiac Electrophysiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccep.2025.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}